Sanofi's Strategic Shift: Spinning Off Consumer Unit and Focusing on R&D
Sanofi plans to spin out its consumer health unit and allocate €2 billion ($2.1 billion) in savings towards research and development efforts. The move is part of the company's strategy to focus on bringing the next wave of medical advances to market, following the trend set by other large drugmakers. The cuts will take place between 2024 and 2025, with the consumer unit likely becoming an independent French company by the end of next year.